Project Grant HT94252310635
Award Date
9/1/23
Completion Date
8/31/25
Dollars Obligated
$656K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10032, USA
Similar Awards
The Trustees of Columbia University in the City of New York (Columbia University) was awarded a $658,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from July 1, 2023 to June 30, 2026 targeting inflammatory signals as therapeutic strategies for peripheral T-cell lymphoma. Through this award, Columbia University will investigate medical solutions for lymphoma, a type of cancer...
The Defense Health Agency awarded a $658,000 Project Grant to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "OVERCOMING IMMUNOTHERAPY RESISTANCE IN CCNE1-AMPLIFIED STOMACH CANCER", is intended to support research to improve treatment options for stomach cancer patients. The 3-year project will run from May 1, 2024 to April 30, 2027....
This Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $1,480,500.00 to The Trustees of Columbia University in the City of New York to develop a peptide-based drug delivery system targeting metastatic prostate cancer. The project will run from September 15, 2023 to September 14, 2026. The Department of Defense grant supports basic, applied, and advanced biomedical research with the goal of transforming healthcare for...
The Defense Health Agency awarded a $1,695,794 Project Grant to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, to develop a state-of-the-art microbur-driven non-absorbable epithelial SERT antagonist to treat anxiety and depression in military members and the general public. The grant is funded through the Military Medical Research and Development (CFDA 12.420) program, which supports basic, applied, and advanced biomedical research to...
This federal Project Grant award, provided by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), is supporting research at The Trustees of Columbia University in the City of New York to advance the potential of the WRN gene as a therapeutic target for microsatellite instability-high (MSI-H) cancers. The $1,316,000 award, effective from August 1, 2025 through July 31, 2029, will fund sophisticated biomedical research initiatives...
The Defense Health Agency awarded The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division, a $1,986,275 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of biofabricated, patient-specific skin gloves as a personalized therapy for mitten deformities in epidermolysis bullosa, a rare genetic skin disorder. The project will run from June 15, 2023 to June 14, 2027. The Military...
The Trustees of Columbia University in the City of New York received a $1.9 million Project Grant award from the Department of the Army Medical Command on August 15, 2022 to fund research on Protein Transduction Therapy for Acute Respiratory Distress Syndrome (ARDS). The research will be conducted through August 14, 2025 in New York, NY under the Military Medical Research and Development program (CFDA 12.420). This program supports basic, applied, and advanced biomedical research with the...
This $1,645,000.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program supports advanced biomedical research at The Trustees of Columbia University in the City of New York, focused on "BONE FRACTURE-INDUCED JOINT BLEEDING AND POSTTRAUMATIC OSTEOARTHRITIS". The award period runs from May 1, 2025 through April 30, 2028, and aims to transform healthcare for military service members and the general...
The Trustees of Columbia University in New York City will receive $486,000 from the Defense Health Agency through March 2024 to analyze the adaptive and innate immune response in patients with amyotrophic lateral sclerosis (ALS) who have been treated with antisense oligonucleotides. This Project Grant was awarded on April 1, 2021 under the Military Medical Research and Development program (CFDA 12.420). The Defense Health Agency's Military Medical Research and Development program aims to...
This federal Project Grant award in the amount of $197,400.00, funded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports the development of patient-derived central nervous system (CNS) metastasis models with STK11 inactivation for drug discovery. The award was granted to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, a prominent academic research institution. The project...